| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/28/2008 | CA2674300A1 Process for the production of high-purity 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef] [2] benzazepine and derivatives thereof |
| 08/27/2008 | EP1961420A1 Agent for prevention and treatment of acute renal failure |
| 08/27/2008 | EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators |
| 08/27/2008 | EP1716145B1 Dihydrotetrabenazines and pharmaceutical compositions containing them |
| 08/27/2008 | EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 08/27/2008 | EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 08/27/2008 | EP1349858B1 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 08/27/2008 | CN101253164A Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 08/27/2008 | CN101250187A Fatty amido substituted methylindole quinoline derivatives as well as preparation method and use thereof as anti-tumour drugs |
| 08/26/2008 | US7417153 cis hydroxylation of the double bond of 2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one into a 2-acetyl-5,6-dihydroxy-2-azabicyclo[2.2.1]heptan-3-one, reacting intemediate with aldehyde or ketone or with 2,2-dimethoxypropane into a ketal or acetal, reductive ring opening, then alkaline hydrolysis |
| 08/26/2008 | US7417147 muscarinic receptor antagonist; chronic obstructive pulmonary disease or asthma; synergistic mixture with antiinflammatory corticosteroid, betamimetic agent or antiallergic agent |
| 08/26/2008 | US7417145 Process for total synthesis of ecteinascidins and intermediates therefor |
| 08/26/2008 | US7417069 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
| 08/26/2008 | US7417053 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 08/26/2008 | US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 08/26/2008 | US7417050 Cognition activators; Alzheimer's disease; attention deficit disorders; Parkinson's disease; Huntington's disease; neurodegenerative disease |
| 08/26/2008 | US7417049 Furyl compounds |
| 08/26/2008 | CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/21/2008 | WO2008100459A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | WO2008051523A3 Carbazole derivatives useful as medicaments in cancer therapy |
| 08/21/2008 | WO2008024978A3 Tetrahydroindolone and tetrahydroindazolone derivatives |
| 08/21/2008 | WO2007092641A3 Method for substituted 1h-imidazo[4,5-c]pyridines |
| 08/21/2008 | US20080200490 Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidino Propanamide Compounds as Orl-1-Receptor Antagonists |
| 08/21/2008 | US20080200469 Phthalazinone derivatives |
| 08/21/2008 | CA2678069A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/20/2008 | EP1958938A2 A process for the preparation of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide |
| 08/20/2008 | EP1957458A2 5-(arylsulfonyl)-pyrazolopiperidines |
| 08/20/2008 | EP1745052B1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1485369B1 Blue 3h-naphtho- 2,1-b -pyran derivatives and use thereof |
| 08/20/2008 | EP1453812B1 Cytotoxic agents |
| 08/20/2008 | CN101248054A Thiazole derivatives and use thereof |
| 08/20/2008 | CN101248050A Organic compounds |
| 08/20/2008 | CN101245103A Process for producing cantharidin artificial antigen |
| 08/20/2008 | CN101245070A Novel technique for synthesizing toroid quinazoline protein tyrosine kinase restrainer |
| 08/20/2008 | CN101245069A Process for producing cis-1.3 disubstituted benzyl imidazoline-2-ketone-2H-furo[3.4-d]imidazole-2,4,6- trione |
| 08/20/2008 | CN100412076C New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle |
| 08/20/2008 | CN100412062C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/19/2008 | US7414069 Antituberculosis compounds, Hirsutellones A, B, and C |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096746A1 Spiro compound and use thereof |
| 08/14/2008 | WO2008095912A2 Enantiopure pharmacologically active tricyclic benzimidazoles |
| 08/14/2008 | US20080194837 Potassium Channel Opener Having Benzofuroindole Skeleton |
| 08/14/2008 | US20080194615 Substituted Tetrahydroquinolines |
| 08/14/2008 | US20080194610 e.g. N-[(4-Chlorophenyl)(phenyl)methyl]-2-oxo-2-(1'H,3H-spiro[2-indol-1,4'-piperidin]-1'-yl)ethanamine; vasopressin V1a receptor antagonist; antidepressant, anxiolytic, hypotensive agent; dysmenorrhea, chronic heart failure, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder |
| 08/14/2008 | US20080194568 Pyridomorphinans, Pyridazinomorphinans and Use Thereof |
| 08/14/2008 | US20080194522 Substituted benzopyran-2-ones; competitive binding ligands for MAO inhibition; anxiolytic agents; neurodegenerative diseases, nervous system disorders; drug screening by comparing detectable changes in fluorescence when samples are oxidatively deaminated in the presence of a MAO |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/13/2008 | EP1954698A1 Spirocyclic compounds as hdac inhibitors |
| 08/13/2008 | EP1954290A2 Tricyclic compounds useful as inhibitors of kinases |
| 08/13/2008 | EP1954274A2 Substituted quinolones and methods of use |
| 08/13/2008 | EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 08/13/2008 | EP1541558B1 Heterocyclic compounds having hiv integrase inhibitory activity |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1467993B1 Method for producing scopine esters |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1020445B1 Fused pyridine derivatives |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101243092A Cripowellins and synthetic derivatives thereof used as medicaments |
| 08/13/2008 | CN101243091A Tricyclic compounds useful as 5-serotonin inhibitors and 5-HT1A agonists and antagonists |
| 08/13/2008 | CN101243068A Compounds for the treatment of multi-drug resistant bacterial infections |
| 08/13/2008 | CN101239983A Chiral synthesis method for (-)-galantamin hydrobromide |
| 08/13/2008 | CN101239982A Alkaloids compounds with hepatitis virus resisting activity |
| 08/13/2008 | CN101239953A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans |
| 08/13/2008 | CN101239061A New purpose of aminoperhydro-quinazoline compounds for eliminating clenbnterol in organisms |
| 08/13/2008 | CN100410254C Preparation process of thiatro bromoaminium anhydrous compound |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411063 Process for preparation of maytansinol |
| 08/12/2008 | US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 08/12/2008 | US7410976 acetyl coenzyme A carboxylase inhibitors; to treat various vascular, nervous system, metabolic, genital, digestive system, respiratory, neoplasm and infectious diseases; herbicides; N-{1'-[(4-methoxyquinolin-2-yl)carbonyl]-4-oxospiro[chroman-2,4'-piperidin]-6-yl}acetamide |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410966 Use of and some novel imidazopyridines |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/07/2008 | WO2008094574A2 Furanone compounds and methods of making and using the same |
| 08/07/2008 | WO2008094476A1 Substituted pyrano [2, 3 - b] pyridine derivatives as cannabinoid -1 receptor modulators |
| 08/07/2008 | WO2008094473A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 08/07/2008 | WO2008093881A1 Method for synthesis of nitroxyl radical |
| 08/07/2008 | WO2008093691A1 Protective agent for retinal nerve or optic nerve |
| 08/07/2008 | WO2008093686A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 08/07/2008 | WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| 08/07/2008 | WO2008092877A2 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders |
| 08/07/2008 | WO2008092832A1 Method for producing ammonium hexafluorophosphates |
| 08/07/2008 | WO2008092681A1 Ghrelin receptor modulators |
| 08/07/2008 | WO2007138351A3 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/07/2008 | US20080188645 Synthesis of Nitrodibenzylfuran Chromophore For Photodeprotection of Organic Molecules |
| 08/07/2008 | US20080188544 Lyophilized formulations of salinosporamide a |
| 08/07/2008 | US20080188507 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/07/2008 | US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
| 08/07/2008 | CA2676167A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 08/07/2008 | CA2676162A1 Method for producing ammonium hexafluorophosphates |